Vertex Announces Further Expansion in the Boston Seaport at Dedication of the Jeffrey Leiden Center for Cell and Genetic Therapies

At a dedication today of the new Jeffrey Leiden Center for Cell and Genetic Therapies in Boston’s Seaport, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced plans to build another 344,000 square foot facility in the Seaport to support the company’s continued rapid growth, in particular the expansion of ...

Related Keywords

Boston ,Massachusetts ,United States ,Australia ,Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,America ,Reshma Kewalramani ,Instagram ,Linkedin ,Vertex Foundation ,Twitter ,Jeffrey Leiden Center ,Boston Real Estate Inclusion Fund ,Leiden Center Expansion ,Youtube ,Facebook ,Vertex Pharmaceuticals Incorporated Nasdaq ,Genetic Therapies ,Vertex Pharmaceuticals Incorporated ,Leiden Center ,Executive Chairman ,Jeffrey Leiden ,Related Beal ,Kavanagh Advisory ,Leiden Campus ,Chief Executive Officer ,Innovation District ,North America ,Top Employers ,